查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1776189

胸腔引流導管的全球市場:洞察，競爭情形，市場預測:2032年

Chest Drainage Catheters - Market Insights, Competitive Landscape, and Market Forecast - 2032
出版日期: | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

預計在2025年至2032年的預測期內，胸腔引流導管市場的複合年增長率將達到4.78%。胸腔引流導管的需求受到多種關鍵因素的驅動，其中包括全球日益增多的慢性疾病，這些疾病通常需要進行胸腔引流幹預，例如癌症、心血管疾病、惡性胸腔積液、氣胸、血胸和心包膜積液。這些疾病負擔的加重，加上導管技術的進步、醫療保健可近性的提高以及主要市場參與者持續的產品創新，正在創造有利於市場擴張的環境。這些因素共同推動了2025年至2032年預測期內胸腔引流導管的需求，並強化了其在現代醫學中的關鍵作用。

胸腔引流管市場動態：

根據國際癌症研究機構 (2024) 的數據，2022 年共報告了 2,486,750 例氣管癌、支氣管癌和肺癌病例。亞洲佔總數的 63.1%。

這些癌症，尤其是肺癌，通常伴隨復發性胸腔積液，通常使用隧道式或非隧道式胸腔引流管進行安寧療護和治癒治療。癌症負擔的增加，尤其是晚期癌症，直接增加了醫院、腫瘤中心和家庭醫療保健機構對此類導管系統的需求。

除腫瘤外，心血管疾病的流行也是關鍵驅動因素。根據英國心臟基金會 (2024) 的數據，全球約有 6.2 億人患有心臟和循環系統疾病，每 13 人中就有 1 人受到影響。心臟病發作和心臟手術等心血管事件常常會導致心包膜積液和術後積液，因此需要使用閉式胸腔引流導管來預防心包膜填塞並促進復健。

此外，微創、數位化和影像導引手術的日益普及，顯著促進了胸腔引流導管市場的發展，提高了手術準確性、病人安全性和復健效果。微創手術因其減少創傷、降低感染風險和縮短住院時間而受到臨床醫生和患者的青睞。影像導引導管置入，尤其是使用超音波和螢光透視，能夠實現精確定位，並最大限度地減少組織損傷和錯位等併發症。數位技術的進步，例如配備流量感測器和壓力監測器的智慧導管，能夠實現即時引流監測、併發症的早期發現以及術後管理的改善。這些進步不僅提高了臨床效率和患者預後，也符合全球醫療保健趨勢，即青睞門診護理和經濟高效的解決方案。

因此，全球癌症和心臟病負擔的不斷增加，推動了對安全、有效和微創胸腔引流解決方案的需求，預計這將在2025年至2032年的預測期內顯著推動胸腔引流導管市場的增長。

然而，胸腔引流導管的複雜性和局限性，以及嚴格的監管要求，是可能限制胸腔引流導管市場成長的主要限制因素。

胸腔引流管市場區隔分析：

產品類型（胸腔引流管、胸腔引流管、套管針導管、其他）、材質（矽膠、PVC（聚氯乙烯）、其他）、應用（心胸外科、胸腔積液、創傷外科、氣胸、其他）、最終用戶（醫院、門診手術中心、其他）、地區（北美、歐洲、亞太地區、其他）

按產品類型劃分的胸腔引流管市場中，預計胸腔引流管類別將在2024年佔據最大的市場佔有率。由於胸腔引流管在胸腔積水、氣胸、血胸和其他需要胸腔引流管治療的胸部疾病中的應用日益增多，因此它正在顯著推動整個胸腔引流管市場的發展。從胸腔排出液體或空氣。隨著肺癌、充血性心臟衰竭、感染和創傷等相關胸膜疾病發生率的上升，無論是在急性護理還是長期照護環境中，對胸腔引流解決方案的需求都在穩步增長。

這些導管，尤其是像 PleurX™ 系統這樣的隧道式留置胸腔導管 (TIPC)，已成為治療復發性或慢性胸腔積液的首選解決方案，為反复胸腔穿刺和住院手術提供了一種創傷性更小、更方便患者的門診替代方案。這些導管為反覆胸腔穿刺和住院手術提供了創傷性較小、更方便患者的替代方案，使門診甚至居家照護成為可能。這種向微創和門診治療的轉變與更廣泛的醫療保健趨勢一致，包括控製成本、縮短住院時間和提高患者舒適度，從而擴大了胸腔引流導管的市場潛力。

此外，導管設計的進步，例如更小直徑的導管以提高引流效率、抗菌塗層以及與數位引流系統的集成，正在提高安全性和臨床療效，進一步推動其應用。因此，製造商正在投資擴大其胸腔導管產品組合，瞄準已開發市場和新興市場。加之不斷增長的臨床需求、技術創新、病患對微創治療的偏好，以及胸腔引流導管在腫瘤學和安寧療護中的日益普及，胸腔引流導管已成為推動整個胸腔引流導管市場成長的關鍵驅動力。

鑑於這些趨勢，預計在2025年至2032年的預測期內，胸腔引流導管類別將實現顯著增長，從而顯著促進整個胸腔引流導管市場的擴張。

預計北美將主導整個胸腔引流導管市場：

預計到2024年，北美將在胸腔引流導管市場佔據最大佔有率，這主要得益於幾個關鍵因素。這一區域主導地位主要源自於人口趨勢、臨床需求和技術進步，這些因素共同促成了強勁的市場需求。主要的成長動力是癌症患者數量的增加，尤其是胸腔積水患者，這些患者通常使用胸腔引流導管進行治療。此外，主要市場參與者的存在和完善的醫療保健基礎設施進一步鞏固了北美在2025年至2032年預測期內作為胸腔引流導管領先市場的地位。

例如，根據GLOBOCAN (2024) 的數據，美國報告了226,033例氣管癌、支氣管癌和肺癌病例，佔該地區癌症病例的87.9%。同樣，加拿大在2022年記錄了31,157例。這些癌症通常會導致惡性胸腔積水等併發症，需要進行胸腔幹預，包括胸腔引流導管，以有效管理液體。隨著這些疾病的盛行率持續上升，對可靠且高效的引流系統的需求也在增長，從而推動了市場的成長。

此外，美國老年人口的成長也顯著促進了市場擴張。老年人更容易患有腫瘤疾病和慢性心肺疾病，這些疾病通常需要胸部幹預，包括胸腔引流系統。對早期診斷和及時幹預以管理肺部和心臟周圍積液的需求日益增長，這推動了醫療機構對胸腔引流導管的採用。

心血管疾病也是推動需求的關鍵因素。根據美國疾病管制與預防中心 (CDC, 2024) 的數據，美國每 20 名 20 歲及以上成年人中就有 1 名患有冠心病，每年約有 805,000 人心臟病發作。

許多此類病例需要術後引流或處理心包膜積液，而胸腔引流導管通常用於預防併發症和促進復健。

此外，完善的醫療保健基礎設施、強有力的報銷政策以及 BD、Cook 和 Teleflex Incorporated 等主要市場參與者的存在，使該地區成為未來幾年全球胸腔引流導管市場的主要貢獻者。

綜合來看，上述因素預計將在2025年至2032年的預測期內重振北美胸腔引流導管市場。

胸腔引流導管市場的主要參與者

胸腔引流導管市場的主要參與者包括 BD、Teleflex Incorporated、Cook、ICU Medical、Redax S.p.A.、Cardinal Health、Mediplus Ltd.、Medela AG、Rocket Medical plc.、Utah Medical Products, Inc.、ANGIPLAST PRIVATE LIMITED、Vygon、Getinge Ltd、Poly.

胸腔引流導管市場的最新發展：

  • 2021年6月，全球領先的醫療科技公司 BD 宣布已獲得美國食品藥物管理局的 510(k) 許可。美國食品藥物管理局 (FDA) 已批准其 PeritX™ 腹膜導管系統。此系統用於引流症狀性、復發性、非惡性腹水，其特徵為腹腔內積水。

胸腔引流管市場研究報告的主要發現

  • 目前胸腔引流管市場規模分析（2024 年）及八年市場預測（2025-2032 年）
  • 過去三年主要產品/技術發展、合併、收購、合作及合資企業
  • 主導胸腔引流管市場的主要公司
  • 胸腔引流管市場中競爭對手面臨的各種機會
  • 哪些細分市場將在 2024 年名列前茅？ 2032 年各細分市場的表現
  • 目前胸腔引流導管市場中排名靠前的地區和國家
  • 未來企業應關注胸腔引流導管市場成長機會的地區和國家

本胸腔引流導管市場研究報告的目標對象

  • 胸腔引流導管產品供應商
  • 研究機構和顧問公司
  • 胸腔引流導管相關組織、協會、論壇等
  • 政府機構與企業
  • 新創公司、創投公司和私人企業
  • 胸腔引流導管經銷商和貿易商
  • 有興趣了解更多胸腔引流導管市場及最新技術發展的各類終端用戶

胸腔引流導管市場常見問題

1.什麼是胸腔引流管？

  • 胸腔引流管又稱胸腔導管或胸膜導管。胸腔引流管是一種柔性管，插入胸腔或縱隔，用於排出肺部和心臟周圍的空氣、液體、血液和膿液。它們對於治療氣胸、血胸和胸腔積水等疾病以及胸部或心臟手術後的引流至關重要。這些導管有助於恢復正常呼吸，防止肺部塌陷，並降低感染和其他併發症的風險。它們常用於急診、外科和重症監護。

2.胸腔引流導管的市場

  • 預計在 2025 年至 2032 年的預測期內，胸腔引流管市場將以 4.78% 的複合年增長率成長。

3.胸腔引流管市場驅動因素

  • 胸腔引流管的需求受到多種關鍵因素的驅動，包括全球範圍內癌症、心血管疾病、惡性胸腔積液、氣胸、血胸和心包積液等慢性疾病的患病率不斷上升，這些疾病通常需要進行胸腔引流幹預。這些疾病負擔的日益加重，加上導管技術的進步、醫療保健可及性的提高以及主要市場參與者持續的產品創新，正在創造有利於市場擴張的環境。這些綜合因素在2025年至2032年的預測期內推動了胸腔引流管的需求，並強化了胸腔引流管在現代醫學中的關鍵作用。

4.胸腔引流導管市場的主要公司

  • 胸腔引流導管市場的主要參與者包括 BD、Teleflex Incorporated、Cook、ICU Medical、Redax S.p.A.、Cardinal Health、Mediplus Ltd.、Medela AG、Rocket Medical plc.、Utah Medical Products, Inc.、ANGIPLAST PRIVATE LIMITED、Vygon、Getinge Ltd、Poly.

5. 胸腔引流導管市場中市佔率最大的地區

  • 預計北美將在 2024 年佔據胸腔引流導管市場的最大佔有率，這基於以下幾個關鍵因素：這一區域優勢可以歸因於人口趨勢、臨床需求和技術進步的共同作用，這些因素共同促成了強勁的市場需求。主要的成長動力是癌症患者數量的增加，尤其是胸腔積水患者，通常使用胸腔引流導管進行治療。此外，主要市場參與者的存在和完善的醫療保健基礎設施進一步鞏固了北美在2025年至2032年預測期內作為胸腔引流導管領先市場的地位。

目錄

第1章 胸腔引流導管市場報告的簡介

第2章 胸腔引流導管市場摘要整理

第3章 競爭情形

第4章 法規分析

  • 美國
  • 歐洲
  • 日本
  • 中國

第5章 胸腔引流導管市場主要原因分析

  • 胸腔引流導管推動市場要素
    • 慢性病發生率上升
    • 微創、數位化和影像導引手術的普及率不斷提高
  • 胸腔引流管市場的限制與課題
    • 胸腔引流管的複雜性與局限性
    • 嚴格的監理要求
  • 胸腔引流管市場機會
    • 導管設計的創新，例如具有防扭結和抗菌塗層的小直徑和生物相容性導管

第6章 胸腔引流導管市場:波特的五力分析

第7章 胸腔引流導管市場評估

  • 各產品類型
    • 胸部導管
    • 胸膜引流導管
    • 穿刺套管導管
    • 其他
  • 不同材料
    • 矽膠
    • PVC(聚氯乙烯)
  • 各用途
    • 心臟胸部外科
    • 胸水
    • 外傷手術
    • 氣胸
  • 各終端用戶
    • 醫院
    • 門診病人手術中心
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 其他地區

第8章 胸腔引流導管市場企業與產品簡介

  • BD
  • Teleflex Incorporated
  • Cook
  • ICU Medical
  • Redax S.p.A.
  • Cardinal Health
  • Mediplus Ltd.
  • Medela AG
  • Rocket Medical plc.
  • Utah Medical Products, Inc.
  • ANGIPLAST PRIVATE LIMITED
  • Vygon
  • Getinge AB
  • Poly Medicure Ltd.
  • Sterimed Group

第9章 KOL的見解

第10章 計劃方法

第11章 關於DelveInsight

第12章 免責聲明和諮詢方式

Product Code: DIMDCL0189

Chest Drainage Catheters Market by Product Type (Thoracic Catheters, Pleural Drainage Catheters, Trocar Catheters, and Others), Material (Silicone, PVC (Polyvinyl Chloride), and Others), Application (Cardiothoracic Surgery, Pleural Effusion, Trauma Surgery, Pneumothorax, and Others), End-User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2032 owing to the rising instances of chronic disorders and increased adoption of minimally invasive, digital, and image-guided procedures across the world.

The chest drainage catheters market is estimated to grow at a CAGR of 4.78% during the forecast period from 2025 to 2032. The demand for chest drainage catheters is being driven by several critical factors, including the rising global prevalence of chronic conditions such as cancer, cardiovascular diseases, malignant pleural effusions, pneumothorax, hemothorax, and pericardial effusions, all of which frequently require thoracic drainage interventions. The growing burden of these conditions, along with advancements in catheter technology, increased healthcare access, and continued product innovation by key market players, is creating a supportive environment for market expansion. Collectively, these factors are propelling demand and reinforcing the critical role of chest drainage catheters in modern clinical care during the forecast period from 2025 to 2032.

Chest Drainage Catheters Market Dynamics:

According to data from the International Agency for Research on Cancer (2024), in the year 2022, there were 24,80,675 reported cases of Trachea, bronchus, and lung cancer. Out of which Asia accounted for 63.1% of all the cases.

These types of cancers, particularly lung are often associated with recurrent pleural effusions, a condition managed using tunneled or non-tunneled chest drainage catheters for palliative and therapeutic care. The growing cancer burden, especially in advanced-stage disease, is directly increasing the demand for such catheter systems across hospitals, oncology centers, and home care settings.

In addition to oncology, the prevalence of cardiovascular diseases is also a significant driver. According to the British Heart Foundation (2024), approximately 620 million people globally were living with heart and circulatory diseases, and 1 in 13 individuals worldwide was affected by such conditions. Cardiovascular events, such as heart attacks and cardiac surgeries, frequently result in pericardial effusions or postoperative fluid accumulation, necessitating the use of closed-system chest drainage catheters to prevent cardiac tamponade and promote recovery.

Furthermore, the increased adoption of minimally invasive, digital, and image-guided procedures is significantly boosting the chest drainage catheter market by enhancing procedural precision, patient safety, and recovery outcomes. Minimally invasive techniques reduce trauma, lower the risk of infection, and shorten hospital stays, making them highly preferred by both clinicians and patients. Image-guided catheter placements especially those using ultrasound or fluoroscopy enable accurate positioning, minimizing complications such as tissue damage or malposition. Digital innovations, such as smart catheters equipped with flow sensors and pressure monitors, are enabling real-time drainage monitoring, early detection of complications, and better postoperative management. These advancements not only improve clinical efficiency and patient outcomes but also align with global healthcare trends favoring outpatient care and cost-effective solutions.

Therefore, the increasing global burden of cancer and heart disease is driving the need for safe, effective, and minimally invasive thoracic drainage solutions, which in turn is expected to significantly boost the growth of the chest drainage catheters market during the forecast period from 2025 to 2032.

However, the complexity and limitations associated with chest drainage catheters, and stringent regulatory requirements, among others are some of the key constraints that may limit the growth of the chest drainage catheters market.

Chest Drainage Catheters Market Segment Analysis:

Product Type (Thoracic Catheters, Pleural Drainage Catheters, Trocar Catheters, and Others), Material (Silicone, PVC (Polyvinyl Chloride), and Others), Application (Cardiothoracic Surgery, Pleural Effusion, Trauma Surgery, Pneumothorax, and Others), End-User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product type segment of the chest drainage catheters market, the pleural drainage catheters category is estimated to account for the largest market share in 2024. Pleural drainage catheters are significantly boosting the overall chest drainage catheter market due to their growing use in the management of pleural effusions, pneumothorax, hemothorax, and other thoracic conditions requiring fluid or air evacuation from the pleural cavity. With the rising incidence of pleural diseases often linked to lung cancer, congestive heart failure, infections, and trauma the demand for pleural drainage solutions has increased steadily across both acute care and long-term care settings.

These catheters, especially tunneled indwelling pleural catheters (TIPCs) such as the PleurX(TM) system, have become the preferred solution for managing recurrent or chronic pleural fluid accumulation, offering a less invasive, outpatient-based alternative to repeated thoracentesis or hospital-based procedures. These catheters, offer a less invasive and more patient-friendly alternative to repeated thoracentesis and hospital-based procedures, enabling outpatient and even home-based care. This shift toward minimally invasive and ambulatory care practices aligns with broader healthcare trends, including cost containment, reduced hospital stays, and improved patient comfort, which in turn expands the market potential for pleural drainage catheters.

Furthermore, ongoing advancements in catheter design such as smaller diameter catheters with better drainage efficiency, anti-microbial coatings, and integration with digital drainage systems are enhancing safety and clinical outcomes, further encouraging adoption. As a result, manufacturers are investing in expanding their pleural catheter product portfolios, targeting both developed and emerging markets. Collectively, the rising clinical demand, technological innovation, patient preference for less invasive care, and the expanding use of pleural drainage catheters in cancer and palliative care are making them a critical driver of growth in the overall chest drainage catheter market.

Given these trends, the pleural drainage catheters category is expected to generate substantial growth and significantly contribute to the overall expansion of the chest drainage catheters market throughout the forecast period of 2025 to 2032.

North America is expected to dominate the overall chest drainage catheters market:

North America is projected to hold the largest share of the chest drainage catheters market in 2024, driven by several key factors. This regional dominance is largely driven by a combination of demographic trends, clinical needs, and technological advancements that collectively contribute to strong market demand. A key growth factor is the increasing number of cancer patients, particularly those suffering from malignant pleural effusions, a condition commonly managed with chest drainage catheters. Additionally, the presence of key market players and a well-established healthcare infrastructure further solidify North America's position as the leading market for chest drainage catheters throughout the forecast period from 2025 to 2032.

For instance, according to GLOBOCAN (2024), the United States reported 226,033 cases of trachea, bronchus, and lung cancers, accounting for 87.9% of such cases in the region. Similarly, Canada recorded 31,157 cases in 2022. These cancers frequently lead to complications such as malignant pleural effusions, which require thoracic interventions involving chest drainage catheters for effective fluid management. As the prevalence of these conditions continues to rise, so does the need for reliable and efficient drainage systems, thereby propelling market growth.

Furthermore, the growing geriatric population in the U.S. is significantly contributing to market expansion. Older adults are more prone to developing both oncological conditions and chronic cardiopulmonary diseases, which often require thoracic interventions involving chest drainage systems. The increasing need for early diagnosis and timely intervention in managing fluid accumulation around the lungs and heart is propelling the adoption of chest drainage catheters across healthcare facilities.

Cardiovascular diseases are another key factor fueling demand. According to the Centers for Disease Control and Prevention (CDC, 2024), 1 in 20 adults aged 20 and older suffers from coronary heart disease in the U.S., and approximately 805,000 people experience heart attacks annually.

Many of these cases require post-surgical drainage or management of pericardial effusions, where chest drainage catheters are routinely employed to prevent complications and support recovery.

In addition, the supportive healthcare infrastructure, strong reimbursement policies, and the presence of key market players such as BD, Cook, and Teleflex Incorporated also position the region as a dominant contributor to the global chest drainage catheters market in the upcoming years.

Collectively, the aforementioned factors are expected to boost the market for chest drainage catheters in North America during the forecast period from 2025 to 2032.

Chest Drainage Catheters Market Key Players:

Some of the key market players operating in the chest drainage catheters market include BD, Teleflex Incorporated, Cook, ICU Medical, Redax S.p.A., Cardinal Health, Mediplus Ltd., Medela AG, Rocket Medical plc., Utah Medical Products, Inc., ANGIPLAST PRIVATE LIMITED, Vygon, Getinge AB, Poly Medicure Ltd., Sterimed Group, and others.

Recent Developmental Activities in the Chest Drainage Catheters Market:

  • In June 2021, BD, a global leader in medical technology, announced that it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its PeritX(TM) Peritoneal Catheter System. The device is intended for the drainage of symptomatic, recurrent non-malignant ascites, a debilitating condition characterized by the accumulation of fluid in the abdominal cavity.

Key takeaways from the chest drainage catheters market report study

  • Market size analysis for current chest drainage catheters market size (2024), and market forecast for 8 years (2025 to 2032)
  • Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years.
  • Key companies dominating the chest drainage catheters market.
  • Various opportunities available for the other competitors in the chest drainage catheters market space.
  • What are the top-performing segments in 2024? How these segments will perform in 2032?
  • Which are the top-performing regions and countries in the current chest drainage catheters market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for chest drainage catheter market growth in the coming future?

Target audience who can benefit from this chest drainage catheters market report study

  • Chest drainage catheter product providers
  • Research organizations and consulting companies
  • Chest drainage catheters-related organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and traders dealing in chest drainage catheters
  • Various end-users who want to know more about the chest drainage catheters market and the latest technological developments in the chest drainage catheters market.

Frequently Asked Questions for the Chest Drainage Catheters Market:

1. What are chest drainage catheters?

  • Chest drainage catheters, also known as thoracic or pleural catheters, are flexible tubes inserted into the pleural space or mediastinum to remove air, fluid, blood, or pus from around the lungs or heart. They are essential in treating conditions such as pneumothorax, hemothorax, pleural effusion, and postoperative drainage following thoracic or cardiac surgery. These catheters help restore normal breathing mechanics, prevent lung collapse, and reduce the risk of infection or other complications. They are commonly used in emergency, surgical, and critical care settings.

2. What is the market for chest drainage catheters?

  • The chest drainage catheters market is estimated to grow at a CAGR of 4.78% during the forecast period from 2025 to 2032.

3. What are the drivers for the chest drainage catheters market?

  • The demand for chest drainage catheters is being driven by several critical factors, including the rising global prevalence of chronic conditions such as cancer, cardiovascular diseases, malignant pleural effusions, pneumothorax, hemothorax, and pericardial effusions, all of which frequently require thoracic drainage interventions. The growing burden of these conditions, along with advancements in catheter technology, increased healthcare access, and continued product innovation by key market players, is creating a supportive environment for market expansion. Collectively, these factors are propelling demand and reinforcing the critical role of chest drainage catheters in modern clinical care during the forecast period from 2025 to 2032

4. Who are the key players operating in the chest drainage catheters market?

  • Some of the key market players operating in the chest drainage catheters market include BD, Teleflex Incorporated, Cook, ICU Medical, Redax S.p.A., Cardinal Health, Mediplus Ltd., Medela AG, Rocket Medical plc., Utah Medical Products, Inc., ANGIPLAST PRIVATE LIMITED, Vygon, Getinge AB, Poly Medicure Ltd., Sterimed Group, and others.

5. Which region has the highest share in the chest drainage catheters market?

  • North America is projected to hold the largest share of the chest drainage catheters market in 2024, driven by several key factors. This regional dominance is largely driven by a combination of demographic trends, clinical needs, and technological advancements that collectively contribute to strong market demand. A key growth factor is the increasing number of cancer patients, particularly those suffering from malignant pleural effusions, a condition commonly managed with chest drainage catheters. Additionally, the presence of key market players and a well-established healthcare infrastructure further solidify North America's position as the leading market for chest drainage catheters throughout the forecast period from 2025 to 2032.

Table of Contents

1. Chest Drainage Catheters Market Report Introduction

  • 1.1. Scope of the Study
  • 1.2. Market Segmentation
  • 1.3. Market Assumption

2. Chest Drainage Catheters Market Executive Summary

  • 2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

  • 4.1. The United States
  • 4.2. Europe
  • 4.3. Japan
  • 4.4. China

5. Chest Drainage Catheters Market Key Factors Analysis

  • 5.1. Chest Drainage Catheters Market Drivers
    • 5.1.1. Rising instances of chronic disorders
    • 5.1.2. Increased adoption of minimally invasive, digital, and image-guided procedure
  • 5.2. Chest Drainage Catheters Market Restraints and Challenges
    • 5.2.1. Complexity and limitations associated with chest drainage catheters
    • 5.2.2. Stringent regulatory requirement
  • 5.3. Chest Drainage Catheters Market Opportunity
    • 5.3.1. Innovation in catheter design such as smaller-bore and biocompatible catheters with anti-kinking and anti-microbial coatings

6. Chest Drainage Catheters Market Porter's Five Forces Analysis

  • 6.1. Bargaining Power of Suppliers
  • 6.2. Bargaining Power of Consumers
  • 6.3. Threat of New Entrants
  • 6.4. Threat of Substitutes
  • 6.5. Competitive Rivalry

7. Chest Drainage Catheters Market Assessment

  • 7.1. By Product Type
    • 7.1.1. Thoracic Catheters
    • 7.1.2. Pleural Drainage Catheters
    • 7.1.3. Trocar Catheters
    • 7.1.4. Others
  • 7.2. By Material
    • 7.2.1. Silicone
    • 7.2.2. PVC (Polyvinyl Chloride)
    • 7.2.3. Others
  • 7.3. By Application
    • 7.3.1. Cardiothoracic Surgery
    • 7.3.2. Pleural Effusion
    • 7.3.3. Trauma Surgery
    • 7.3.4. Pneumothorax
    • 7.3.5. Others
  • 7.4. By End-User
    • 7.4.1. Hospitals
    • 7.4.2. Ambulatory Surgical Centers
    • 7.4.3. Others
  • 7.5. By Geography
    • 7.5.1. North America
      • 7.5.1.1. United States Chest Drainage Catheters Market Size in USD million (2022-2032)
      • 7.5.1.2. Canada Chest Drainage Catheters Market Size in USD million (2022-2032)
      • 7.5.1.3. Mexico Chest Drainage Catheters Market Size in USD million (2022-2032)
    • 7.5.2. Europe
      • 7.5.2.1. France Chest Drainage Catheters Market Size in USD million (2022-2032)
      • 7.5.2.2. Germany Chest Drainage Catheters Market Size in USD million (2022-2032)
      • 7.5.2.3. United Kingdom Chest Drainage Catheters Market Size in USD million (2022-2032)
      • 7.5.2.4. Italy Chest Drainage Catheters Market Size in USD million (2022-2032)
      • 7.5.2.5. Spain Chest Drainage Catheters Market Size in USD million (2022-2032)
      • 7.5.2.6. Rest of Europe Chest Drainage Catheters Market Size in USD million (2022-2032)
    • 7.5.3. Asia-Pacific
      • 7.5.3.1. China Chest Drainage Catheters Market Size in USD million (2022-2032)
      • 7.5.3.2. Japan Chest Drainage Catheters Market Size in USD million (2022-2032)
      • 7.5.3.3. India Chest Drainage Catheters Market Size in USD million (2022-2032)
      • 7.5.3.4. Australia Chest Drainage Catheters Market Size in USD million (2022-2032)
      • 7.5.3.5. South Korea Chest Drainage Catheters Market Size in USD million (2022-2032)
      • 7.5.3.6. Rest of Asia-Pacific Chest Drainage Catheters Market Size in USD million (2022-2032)
    • 7.5.4. Rest of the World (RoW)
      • 7.5.4.1. Middle East Chest Drainage Catheters Market Size in USD million (2022-2032)
      • 7.5.4.2. Africa Chest Drainage Catheters Market Size in USD million (2022-2032)
      • 7.5.4.3. South America Chest Drainage Catheters Market Size In USD Million (2022-2032)

8. Chest Drainage Catheters Market Company and Product Profiles

  • 8.1. BD
    • 8.1.1. Company Overview
    • 8.1.2. Company Snapshot
    • 8.1.3. Financial Overview
    • 8.1.4. Product Listing
    • 8.1.5. Entropy
  • 8.2. Teleflex Incorporated
    • 8.2.1. Company Overview
    • 8.2.2. Company Snapshot
    • 8.2.3. Financial Overview
    • 8.2.4. Product Listing
    • 8.2.5. Entropy
  • 8.3. Cook
    • 8.3.1. Company Overview
    • 8.3.2. Company Snapshot
    • 8.3.3. Financial Overview
    • 8.3.4. Product Listing
    • 8.3.5. Entropy
  • 8.4. ICU Medical
    • 8.4.1. Company Overview
    • 8.4.2. Company Snapshot
    • 8.4.3. Financial Overview
    • 8.4.4. Product Listing
    • 8.4.5. Entropy
  • 8.5. Redax S.p.A.
    • 8.5.1. Company Overview
    • 8.5.2. Company Snapshot
    • 8.5.3. Financial Overview
    • 8.5.4. Product Listing
    • 8.5.5. Entropy
  • 8.6. Cardinal Health
    • 8.6.1. Company Overview
    • 8.6.2. Company Snapshot
    • 8.6.3. Financial Overview
    • 8.6.4. Product Listing
    • 8.6.5. Entropy
  • 8.7. Mediplus Ltd.
    • 8.7.1. Company Overview
    • 8.7.2. Company Snapshot
    • 8.7.3. Financial Overview
    • 8.7.4. Product Listing
    • 8.7.5. Entropy
  • 8.8. Medela AG
    • 8.8.1. Company Overview
    • 8.8.2. Company Snapshot
    • 8.8.3. Financial Overview
    • 8.8.4. Product Listing
    • 8.8.5. Entropy
  • 8.9. Rocket Medical plc.
    • 8.9.1. Company Overview
    • 8.9.2. Company Snapshot
    • 8.9.3. Financial Overview
    • 8.9.4. Product Listing
    • 8.9.5. Entropy
  • 8.10. Utah Medical Products, Inc.
    • 8.10.1. Company Overview
    • 8.10.2. Company Snapshot
    • 8.10.3. Financial Overview
    • 8.10.4. Product Listing
    • 8.10.5. Entropy
  • 8.11. ANGIPLAST PRIVATE LIMITED
    • 8.11.1. Company Overview
    • 8.11.2. Company Snapshot
    • 8.11.3. Financial Overview
    • 8.11.4. Product Listing
    • 8.11.5. Entropy
  • 8.12. Vygon
    • 8.12.1. Company Overview
    • 8.12.2. Company Snapshot
    • 8.12.3. Financial Overview
    • 8.12.4. Product Listing
    • 8.12.5. Entropy
  • 8.13. Getinge AB
    • 8.13.1. Company Overview
    • 8.13.2. Company Snapshot
    • 8.13.3. Financial Overview
    • 8.13.4. Product Listing
    • 8.13.5. Entropy
  • 8.14. Poly Medicure Ltd.
    • 8.14.1. Company Overview
    • 8.14.2. Company Snapshot
    • 8.14.3. Financial Overview
    • 8.14.4. Product Listing
    • 8.14.5. Entropy
  • 8.15. Sterimed Group
    • 8.15.1. Company Overview
    • 8.15.2. Company Snapshot
    • 8.15.3. Financial Overview
    • 8.15.4. Product Listing
    • 8.15.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: Chest Drainage Catheters Market in Global (2022-2032)
  • Table 3: Chest Drainage Catheters Market in Global by Product Type (2022-2032)
  • Table 4: Chest Drainage Catheters Market in Global by Material (2022-2032)
  • Table 5: Chest Drainage Catheters Market in Global by Application (2022-2032)
  • Table 6: Chest Drainage Catheters Market in Global by End-User (2022-2032)
  • Table 7: Chest Drainage Catheters Market in Global by Geography (2022-2032)
  • Table 8: Chest Drainage Catheters Market in North America (2022-2032)
  • Table 9: Chest Drainage Catheters Market in the United States (2022-2032)
  • Table 10: Chest Drainage Catheters Market in Canada (2022-2032)
  • Table 11: Chest Drainage Catheters Market in Mexico (2022-2032)
  • Table 12: Chest Drainage Catheters Market in Europe (2022-2032)
  • Table 13: Chest Drainage Catheters Market in France (2022-2032)
  • Table 14: Chest Drainage Catheters Market in Germany (2022-2032)
  • Table 15: Chest Drainage Catheters Market in United Kingdom (2022-2032)
  • Table 16: Chest Drainage Catheters Market in Italy (2022-2032)
  • Table 17: Chest Drainage Catheters Market in Spain (2022-2032)
  • Table 18: Chest Drainage Catheters Market in the Rest of Europe (2022-2032)
  • Table 19: Chest Drainage Catheters Market in Asia-Pacific (2022-2032)
  • Table 20: Chest Drainage Catheters Market in China (2022-2032)
  • Table 21: Chest Drainage Catheters Market in Japan (2022-2032)
  • Table 22: Chest Drainage Catheters Market in India (2022-2032)
  • Table 23: Chest Drainage Catheters Market in Australia (2022-2032)
  • Table 24: Chest Drainage Catheters Market in South Korea (2022-2032)
  • Table 25: Chest Drainage Catheters Market in Rest of Asia-Pacific (2022-2032)
  • Table 26: Chest Drainage Catheters Market in the Rest of the World (2022-2032)
  • Table 27: Chest Drainage Catheters Market in the Middle East (2022-2032)
  • Table 28: Chest Drainage Catheters Market in Africa (2022-2032)
  • Table 29: Chest Drainage Catheters Market in South America (2022-2032)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: Chest Drainage Catheters Market in Global (2022-2032)
  • Figure 3: Chest Drainage Catheters Market in Global by Product Type (2022-2032)
  • Figure 4: Chest Drainage Catheters Market in Global by Material (2022-2032)
  • Figure 5: Chest Drainage Catheters Market in Global by Application (2022-2032)
  • Figure 6: Chest Drainage Catheters Market in Global by End-User (2022-2032)
  • Figure 7: Chest Drainage Catheters Market in Global by Geography (2022-2032)
  • Figure 8: Chest Drainage Catheters Market in North America (2022-2032)
  • Figure 9: Chest Drainage Catheters Market in the United States (2022-2032)
  • Figure 10: Chest Drainage Catheters Market in Canada (2022-2032)
  • Figure 11: Chest Drainage Catheters Market in Mexico (2022-2032)
  • Figure 12: Chest Drainage Catheters Market in Europe (2022-2032)
  • Figure 13: Chest Drainage Catheters Market in France (2022-2032)
  • Figure 14: Chest Drainage Catheters Market in Germany (2022-2032)
  • Figure 15: Chest Drainage Catheters Market in United Kingdom (2022-2032)
  • Figure 16: Chest Drainage Catheters Market in Italy (2022-2032)
  • Figure 17: Chest Drainage Catheters Market in Spain (2022-2032)
  • Figure 18: Chest Drainage Catheters Market in the Rest of Europe (2022-2032)
  • Figure 19: Chest Drainage Catheters Market in Asia-Pacific (2022-2032)
  • Figure 20: Chest Drainage Catheters Market in China (2022-2032)
  • Figure 21: Chest Drainage Catheters Market in Japan (2022-2032)
  • Figure 22: Chest Drainage Catheters Market in India (2022-2032)
  • Figure 23: Chest Drainage Catheters Market in Australia (2022-2032)
  • Figure 24: Chest Drainage Catheters Market in South Korea (2022-2032)
  • Figure 25: Chest Drainage Catheters Market in Rest of Asia-Pacific (2022-2032)
  • Figure 26: Chest Drainage Catheters Market in the Rest of the World (2022-2032)
  • Figure 27: Chest Drainage Catheters Market in the Middle East (2022-2032)
  • Figure 28: Chest Drainage Catheters Market in Africa (2022-2032)
  • Figure 29: Chest Drainage Catheters Market in South America (2022-2032)
  • Figure 30: Market Drivers
  • Figure 31: Market Barriers
  • Figure 32: Marker Opportunities
  • Figure 33: PORTER'S Five Force Analysis